Paper488922
Prognostic significance of the histological features of malignant melanoma.
McGovern VJ and 3 others. Histopathology, 1979. Cited by 165 papers, by iCite.
Cite this record
ConductScience Library. Prognostic significance of the histological features of malignant melanoma. Papers, record 488922. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/488922
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics4
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Melanoma | Major topic |
| Humans | |
| Neoplasm Staging | |
| Prognosis |
Source PubMed
Cited by22
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 165 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 30381323 | Disparities in diagnosis of advanced melanoma: a population-based cohort study. | CMAJ Open | 2018 | https://conductscience.org/library/papers/30381323 | PubMed |
| 27502743 | Breslow density is a novel prognostic feature in cutaneous malignant melanoma. | Histopathology | 2017 | https://conductscience.org/library/papers/27502743 | PubMed |
| 23785613 | "Mitogenicity"-the latest and mosthilarious episode in the slapstick comedy of melanoma management. | Dermatol Pract Concept | 2012 | https://conductscience.org/library/papers/23785613 | PubMed |
| 8199108 | Prognostic factors in primary malignant melanoma of the conjunctiva: a clinicopathological study of 256 cases. | Br J Ophthalmol | 1994 | https://conductscience.org/library/papers/8199108 | PubMed |
| 7149819 | A comparison of prognostic factors and surgical results in 1,786 patients with localized (stage I) melanoma treated in Alabama, USA, and New South Wales, Australia. | Ann Surg | 1982 | https://conductscience.org/library/papers/7149819 | PubMed |
| 6822677 | Prognostic value of tumour thickness in cutaneous malignant melanoma. | J Clin Pathol | 1983 | https://conductscience.org/library/papers/6822677 | PubMed |
| 6508408 | Head and neck melanoma in 534 clinical Stage I patients. A prognostic factors analysis and results of surgical treatment. | Ann Surg | 1984 | https://conductscience.org/library/papers/6508408 | PubMed |
| 6508406 | The frequency of local recurrence and microsatellites as a guide to reexcision margins for cutaneous malignant melanoma. | Ann Surg | 1984 | https://conductscience.org/library/papers/6508406 | PubMed |
| 6476888 | Prognostic significance of the patient's sex, tumor site, and mitotic rate in thin (less than or equal to 1.5 mm) melanoma. | Arch Dermatol Res | 1984 | https://conductscience.org/library/papers/6476888 | PubMed |
| 6416500 | The incidental malignant melanoma. | Br Med J (Clin Res Ed) | 1983 | https://conductscience.org/library/papers/6416500 | PubMed |
| 6415909 | Histological type and biological behavior of primary cutaneous malignant melanoma. 1. An analysis of 1916 cases. | Virchows Arch A Pathol Anat Histopathol | 1983 | https://conductscience.org/library/papers/6415909 | PubMed |
| 6412848 | The incidental malignant melanoma. | Br Med J (Clin Res Ed) | 1983 | https://conductscience.org/library/papers/6412848 | PubMed |
| 6398936 | The ultrastructure of conjunctival melanocytic tumors. | Trans Am Ophthalmol Soc | 1984 | https://conductscience.org/library/papers/6398936 | PubMed |
| 4015217 | Thin level IV malignant melanoma. A subset in which level is the major prognostic indicator. | Ann Surg | 1985 | https://conductscience.org/library/papers/4015217 | PubMed |
| 3977452 | Thin (less than or equal to 1 mm) melanomas of the extremities are biologically favorable lesions not influenced by regression. | Ann Surg | 1985 | https://conductscience.org/library/papers/3977452 | PubMed |
| 3977262 | Biopsy procedures, primary wide excisional surgery and long term prognosis in primary clinical stage I invasive cutaneous malignant melanoma. | Ann R Coll Surg Engl | 1985 | https://conductscience.org/library/papers/3977262 | PubMed |
| 3923697 | Survival with primary cutaneous malignant melanoma, evaluated from 2012 cases. A multivariate regression analysis. | Virchows Arch A Pathol Anat Histopathol | 1985 | https://conductscience.org/library/papers/3923697 | PubMed |
| 3460702 | Phase II study of vaccinia melanoma cell lysates (VMCL) as adjuvant to surgical treatment of stage II melanoma. II. Effects on cell mediated cytotoxicity and leucocyte dependent antibody activity: immunological effects of VMCL in melanoma patients. | Cancer Immunol Immunother | 1986 | https://conductscience.org/library/papers/3460702 | PubMed |
| 3355269 | Prognostic significance of DNA aneuploidy in stage I cutaneous melanoma. | Ann Surg | 1988 | https://conductscience.org/library/papers/3355269 | PubMed |
| 2815804 | Hyperthermic perfusion with chemotherapy for melanoma of the extremities. | World J Surg | 1989 | https://conductscience.org/library/papers/2815804 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/488922
GET https://conductscience.org/api/papers/v1/488922/cited_by?page=2